The QSR (21 CFR 820): What each subpart really requires
View: 113
Website https://compliance2go.com/product/?pid=CP2014-397 |
Edit Freely
Category Medical Device
Deadline: November 19, 2014 | Date: November 19, 2014
Venue/Country: Houston, U.S.A
Updated: 2014-10-28 19:08:11 (GMT+9)
Call For Papers - CFP
DESCRIPTIONThe QSR regulations - with the exception of 820.30 Design Controls - have not changed significantly over the last several decades. However, the interpretation of each subpart has been shaped and updated with new FDA insight into critical quality processes. Learn about key FDA focus areas in each subpart, how to prevent the most common 483 and warning letter observations and how to establish a lean compliance system within your company. Get tips from an expert in remediation who has helped Fortune 500 medical device companies through risk management, design control, DHF and process validation remediation activities.Why should you attend :The QSR is examined and practical advice is discussed using case studies, 483 and warning letter text and a practical approach to implementing quality improvements and alignment to FDA quality system requirements.Areas Covered in the Session:21 CFR 820 (Subpart A - Subpart O)Who will benefit: (Titles)Engineers Vice PresidentsDirectorsQuality ProfessionalsCompliance Staff and OfficersConsultantsCEOsAnyone Interested in the TopicWebinar Includes:Q/A Session with the Expert to ask your questionPDF print only copy of PowerPoint slides60 Minutes Live PresentationCertificate
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.